IDEX raises 2026 guidance after record second-quarter sales and orders

IDEX reported second-quarter 2026 sales of $920.6 million, up 6% year over year, with diluted EPS of $1.93 and adjusted diluted EPS of $2.32; orders rose 29% to a record $1.07 billion. The company raised its full-year organic sales growth outlook to 5%-6% from 3%-4% and adjusted EPS guidance to $8.70-$8.85 from $8.35-$8.55, while returning $131 million through $77 million of share repurchases and $54 million of dividends.